• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Concerns related to the coronavirus disease 2019 pandemic in adult patients with atopic dermatitis and psoriasis treated with systemic immunomodulatory therapy: a Danish questionnaire survey.

作者信息

Loft N D, Halling A-S, Iversen L, Vestergaard C, Deleuran M, Rasmussen M K, Zachariae C, Thyssen J P, Skov L

机构信息

Department of Dermatology and Allergy, Herlev and Gentofte Hospital, University of Copenhagen, Hellerup, Denmark.

Copenhagen Research Group for Inflammatory Skin (CORGIS), Herlev and Gentofte Hospital, Hellerup, Denmark.

出版信息

J Eur Acad Dermatol Venereol. 2020 Dec;34(12):e773-e776. doi: 10.1111/jdv.16863. Epub 2020 Sep 17.

DOI:10.1111/jdv.16863
PMID:32780487
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7436705/
Abstract
摘要

相似文献

1
Concerns related to the coronavirus disease 2019 pandemic in adult patients with atopic dermatitis and psoriasis treated with systemic immunomodulatory therapy: a Danish questionnaire survey.关于2019冠状病毒病大流行对接受全身免疫调节治疗的特应性皮炎和银屑病成年患者影响的关注：一项丹麦问卷调查
J Eur Acad Dermatol Venereol. 2020 Dec;34(12):e773-e776. doi: 10.1111/jdv.16863. Epub 2020 Sep 17.
2
Use of alternative medicine by patients with atopic dermatitis and psoriasis.特应性皮炎和银屑病患者使用替代医学的情况。
Acta Derm Venereol. 1990;70(5):421-4.
3
Therapeutic preferences are different in psoriatic and atopic dermatitis patients: a questionnaire-based study.银屑病和特应性皮炎患者的治疗偏好不同：一项基于问卷调查的研究。
J Dermatol. 2013 Apr;40(4):292-4. doi: 10.1111/1346-8138.12094. Epub 2013 Feb 11.
4
Differences in efficacy between intention-to-treat and per-protocol analyses for patients with psoriasis vulgaris and atopic dermatitis: clinical and pharmacoeconomic implications.寻常型银屑病和特应性皮炎患者意向性分析与符合方案分析之间的疗效差异：临床及药物经济学意义
Br J Dermatol. 2001 Jun;144(6):1154-60. doi: 10.1046/j.1365-2133.2001.04234.x.
5
Empowering heliotherapy improves clinical outcome and quality of life of psoriasis and atopic dermatitis patients.增强型日光疗法可改善银屑病和特应性皮炎患者的临床疗效及生活质量。
Acta Derm Venereol. 2015 May;95(5):579-82. doi: 10.2340/00015555-2028.
6
Narrowband ultraviolet B phototherapy improves quality of life of psoriasis and atopic dermatitis patients up to 3 months: Results from an observational multicenter study.窄谱中波紫外线光疗可改善银屑病和特应性皮炎患者的生活质量长达 3 个月：一项观察性多中心研究结果。
Photodermatol Photoimmunol Photomed. 2019 Sep;35(5):332-338. doi: 10.1111/phpp.12479. Epub 2019 May 20.
7
Clinical efficacy of Avène hydrotherapy measured in a large cohort of more than 10,000 atopic or psoriatic patients.在超过 10000 名特应性皮炎或银屑病患者的大样本中评估雅漾水疗的临床疗效。
J Eur Acad Dermatol Venereol. 2011 Feb;25 Suppl 1:30-4. doi: 10.1111/j.1468-3083.2010.03900.x.
8
Empowering Heliotherapy in Psoriasis and Atopic Dermatitis: An Observational Study of 186 Subjects.
Acta Derm Venereol. 2017 Feb 8;97(2):255-257. doi: 10.2340/00015555-2506.
9
Underuse of early follow-up visits: a missed opportunity to improve patients' adherence.早期随访就诊利用不足：改善患者依从性的错失机会。
J Drugs Dermatol. 2014 Jul;13(7):833-6.
10
Comparative analysis of the use of complementary and alternative medicine by Korean patients with androgenetic alopecia, atopic dermatitis and psoriasis.韩国雄激素性脱发、特应性皮炎和银屑病患者对补充替代医学的使用比较分析。
J Eur Acad Dermatol Venereol. 2013 Jul;27(7):827-35. doi: 10.1111/j.1468-3083.2012.04583.x. Epub 2012 May 23.

引用本文的文献

1
Advancements in the Study of Biologic Agents in Comorbidities of Psoriasis: A Literature Review.银屑病合并症生物制剂研究进展：文献综述
Clin Cosmet Investig Dermatol. 2023 Dec 4;16:3487-3495. doi: 10.2147/CCID.S439110. eCollection 2023.
2
Epidemiology of Psoriasis and Comorbid Diseases: A Narrative Review.银屑病的流行病学和合并症：一篇叙述性综述。
Front Immunol. 2022 Jun 10;13:880201. doi: 10.3389/fimmu.2022.880201. eCollection 2022.
3
Impact of the COVID-19 pandemic on adults with moderate-to-severe atopic dermatitis in the Dutch general population.新冠疫情对荷兰普通人群中患有中度至重度特应性皮炎的成年人的影响。
JAAD Int. 2022 Mar;6:86-93. doi: 10.1016/j.jdin.2021.12.006. Epub 2021 Dec 28.
4
Administrative data and scientific evidence: a lesson from France - the safety of systemic treatment for psoriasis during the COVID-19 pandemic.行政数据与科学证据：来自法国的经验教训——COVID-19 大流行期间银屑病的系统治疗安全性。
Br J Dermatol. 2022 Jan;186(1):7-8. doi: 10.1111/bjd.20776. Epub 2021 Nov 2.
5
Atopic comorbidity has no impact on severity and course of Coronavirus disease 2019 (COVID-19) in adult patients.特应性共病对成年患者的2019冠状病毒病（COVID-19）的严重程度和病程没有影响。
Ann Allergy Asthma Immunol. 2022 Feb;128(2):218-220. doi: 10.1016/j.anai.2021.10.026. Epub 2021 Oct 28.
6
Management of patients with atopic dermatitis undergoing systemic therapy during COVID-19 pandemic in Italy: Data from the DA-COVID-19 registry.意大利 COVID-19 大流行期间接受全身治疗的特应性皮炎患者的管理：来自 DA-COVID-19 登记处的数据。
Allergy. 2021 Jun;76(6):1813-1824. doi: 10.1111/all.14767. Epub 2021 Mar 9.
7
Psoriasis care during the time of COVID-19: real-world data on changes in treatments and appointments from a German university hospital.新冠疫情期间的银屑病护理：来自德国一家大学附属医院的治疗和预约变化的真实世界数据。
Eur J Dermatol. 2021 Apr 1;31(2):183-191. doi: 10.1684/ejd.2021.4016.

本文引用的文献

1
Systemic or biologic treatment in psoriasis patients does not increase the risk of a severe form of COVID-19.银屑病患者接受全身治疗或生物治疗不会增加患重症 COVID-19 的风险。
J Eur Acad Dermatol Venereol. 2020 Nov;34(11):e676-e679. doi: 10.1111/jdv.16761. Epub 2020 Jul 9.
2
Considerations for safety in the use of systemic medications for psoriasis and atopic dermatitis during the COVID-19 pandemic.COVID-19 大流行期间使用全身性药物治疗银屑病和特应性皮炎的安全性考虑。
Dermatol Ther. 2020 Sep;33(5):e13687. doi: 10.1111/dth.13687. Epub 2020 Jun 19.
3
A survey of psoriasis patients on biologics during COVID-19: a single centre experience.COVID-19期间银屑病患者生物制剂使用情况的调查：单中心经验
J Dermatolog Treat. 2022 Feb;33(1):596. doi: 10.1080/09546634.2020.1770165. Epub 2020 May 25.
4
The impact of the COVID-19 pandemic on patients with chronic plaque psoriasis being treated with biological therapy: the Northern Italy experience.2019年冠状病毒病大流行对接受生物疗法治疗的慢性斑块状银屑病患者的影响：意大利北部的经验。
Br J Dermatol. 2020 Aug;183(2):373-374. doi: 10.1111/bjd.19158. Epub 2020 May 28.
5
No evidence of increased risk for Coronavirus Disease 2019 (COVID-19) in patients treated with Dupilumab for atopic dermatitis in a high-epidemic area - Bergamo, Lombardy, Italy.在意大利伦巴第大区贝加莫这个高疫情地区，接受度普利尤单抗治疗特应性皮炎的患者中，没有证据表明其感染2019冠状病毒病（COVID-19）的风险增加。
J Eur Acad Dermatol Venereol. 2020 Sep;34(9):e433-e434. doi: 10.1111/jdv.16552. Epub 2020 Jun 15.
6
COVID-19: risk for cytokine targeting in chronic inflammatory diseases?COVID-19：慢性炎症性疾病中细胞因子靶向治疗的风险？
Nat Rev Immunol. 2020 May;20(5):271-272. doi: 10.1038/s41577-020-0312-7.
7
Should biologics for psoriasis be interrupted in the era of COVID-19?在新冠疫情时代，银屑病生物制剂是否应中断使用？
J Am Acad Dermatol. 2020 May;82(5):1217-1218. doi: 10.1016/j.jaad.2020.03.031. Epub 2020 Mar 19.
8
COVID-19 and psoriasis: Is it time to limit treatment with immunosuppressants? A call for action.新型冠状病毒肺炎与银屑病：是时候限制免疫抑制剂的使用了吗？呼吁采取行动。
Dermatol Ther. 2020 Jul;33(4):e13298. doi: 10.1111/dth.13298. Epub 2020 Mar 22.